Mayo Clinic and Leidos have formed a strategic collaboration to accelerate research and development of tools, technologies and therapeutics, it was announced on Thursday.
Reston, Virginia-based Leidos, which is a scientific engineering giant, will work with Rochester, Minnesota-based Mayo Clinic to build an ecosystem on Mayo Clinic's Florida campus in Jacksonville aimed at product development.
They plan to identify, develop and commercialize products, services and solutions that will create significant value and positive impact for the healthcare industry, healthcare providers, patients and consumers, officials said.
"The shared values and deep passion for transforming healthcare make this collaboration a powerful force for the advancement of innovative methods and quick translation of these solutions across the healthcare ecosystem," said Jon Scholl, Leidos Health Group president, in a statement. "The clinical knowledge of the Mayo Clinic combined with our technical expertise has the potential to truly transform the quality of healthcare in the future."
Additional details are expected to be released later this spring, officials said.
Mayo has previously inked partnerships with industry such as a 2017 agreement with Deerfield, Illinois-based healthcare giant Baxter International to develop a new center of excellence for chronic kidney disease patients in Florida. They are also partnered with Silver Spring, Maryland-based biotech United Therapeutics to construct a lung restoration facility in Florida.
"We look forward to combining the power of our two organizations that will help us advance new solutions to solve the most complex healthcare challenges," said Kent Thielen, M.D., CEO of Mayo Clinic in Florida, in a statement. "Working together will allow us to spark a vibrant ecosystem to bring innovation to the direct benefit of patients more quickly."